The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

On 15 January 2025, the US Food and Drug Administration (FDA) announced that it will revoke the color additive authorization ...

Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...

VERIFY answers four questions about the common food additive red dye No. 3, including what products contain it and if the FDA ...

It’s the first time regulators have authorized sales of the products, which are the fastest-growing segment of the tobacco ...

A rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far ...

The FDA has banned red dye No. 3 in food and ingested drugs, the agency announced. But what exactly is red dye No. 3, and why ...

Altria (NYSE: MO) owns the Marlboro brand, which has a roughly 41% market share in North America. That's huge and highlights the company's dominance in this geographic region. But the downside ...

Bearish flow noted in Altria Group (MO) with 11,600 puts trading, or 3x expected. Most active are Mar-25 50 puts and Feb-25 55 calls, with total volume in those strikes near 9,900 contracts.

Altria Group Inc. Altria Group (MO ... saw success recently with the Food and Drug Administration approval of the schizophrenia drug Cobenify. This puts the company in a good position to continue ...

Altria Group, Inc. MO stock is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 9.85, representing a 16.9% discount compared to the Zacks Tobacco industry’s average of 11.85.